Screener
Chemours CC Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | (12) | (87) |
| Other current operating liabilities | 217 | 70 |
| Other non-current operating liabilities | 122 | 239 |
| Cash provided by (used for) operating activities | 114 | (19) |
| Cash flows from investing activities | ||
| Purchases of property, plant, and equipment | (93) | (127) |
| Proceeds from life insurance policies | 1 | — |
| Proceeds from sales of assets and businesses | 294 | 1 |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's operating cash flow?
- Chemours (CC) reported operating cash flow of $158M in Q2 2026.
- How has Chemours's operating cash flow changed year-over-year?
- Chemours's operating cash flow increased by 69.9% year-over-year, from $93M to $158M.
- What is the long-term trend for Chemours's operating cash flow?
- Over 3 years (2021 to 2025), Chemours's operating cash flow has grown at a -31.3% compound annual growth rate (CAGR), from $814M to $264M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Chemours's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude